ROCKVILLE, Md. and BEIJING, Aug. 5, 2022
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S.
biopharmaceutical company focused on developing and commercializing
innovative therapeutics and pharmaceutical products, today
announced the Company will host a conference call reviewing the
financial results for the second quarter of 2022, at 8:00 A.M. EST on Friday, August 12th,
2022.
On the call, CASI's Chairman & CEO will provide an update on
the Company's business and upcoming milestones. The conference call
can be accessed by dialing 1-866-218-2402 (U.S.) or 1-412-902-6605
(International) and ask to be joined into the CASI Pharmaceuticals
call to listen to the live conference call. Confirmation
#10169302.
This call will be recorded and available for replay by dialing
1-877-344-7529 (U.S.) or 1-412-317-0088 (International) and enter
9173539 to access the replay.
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company
focused on developing and commercializing innovative therapeutics
and pharmaceutical products in China, the United
States, and throughout the world. The Company is focused on
acquiring, developing, and commercializing products that augment
its hematology oncology therapeutic focus as well as other areas of
unmet medical need. The Company intends to execute its plan to
become a leader by launching medicines in the greater China market leveraging the Company's
China-based regulatory and
commercial competencies and its global drug development expertise.
The Company's operations in China
are conducted through its wholly-owned subsidiary, CASI
Pharmaceuticals (China) Co., Ltd.,
which is located in Beijing,
China. The Company has built a commercial team of more than
100 hematology and oncology sales and marketing specialists based
in China. More information on CASI
is available at www.casipharmaceuticals.com.
COMPANY CONTACT:
Rui Zhang
CASI Pharmaceuticals, Inc.
240.864.2643
ir@casipharmaceuticals.com
|
INVESTOR CONTACT:
Xuan Yang
Solebury Trout
646.378.2975
xyang@soleburytrout.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/casi-pharmaceuticals-to-report-second-quarter-2022-financial-results-and-host-conference-call-august-12-2022-301600771.html
SOURCE CASI Pharmaceuticals, Inc.